Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore
Open Access
- 23 June 2015
- journal article
- research article
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 4 (1), 1-7
- https://doi.org/10.1186/s13756-015-0066-3
Abstract
Carbapenem resistant Enterobacteriaceae (CRE) is increasingly reported worldwide. A similar increase is seen in Singapore since identification of its first case in 2008. The aim of this study was to identify local risk factors for carriage of CRE in patients from an acute tertiary care hospital in Singapore. A matched case-control study was conducted on inpatients treated from January 1, 2011 till December 31, 2013. Two hundred and three cases of CRE infection or colonization were matched with 203 controls. CRE types were identified by PCR. Statistical analysis of data including a multivariate logistic regression analysis was done using SPSS 21.0. CREs were commonly seen in Klebsiella pneumoniae (42.2 %), Escherichia coli (24.3 %) and Enterobacter cloacae complex (17.2 %) in the 268 isolates. NDM-1 was the commonest CRE type seen (44.4 %), followed by KPC (39.9 %) whilst OXA-48 only constituted (7.8 %). Univariate analysis identified key risk factors associated with CRE as history of previous overseas hospitalization (OR: 33.667; 95 % CI: 4.539-259.700), admission to ICU (OR: 11.899; 95 % CI: 4.986-28.399) and HD/ICA (OR: 6.557; 95 % CI: 4.057-10.596); whilst a multivariate analysis revealed exposure to antibiotics penicillin (OR: 4.640; 95 % CI: 1.529-14.079] and glycopeptide (OR: 5.162; 95 % CI: 1.377-19.346) and presence of central line device (OR: 3.117; 95 % CI: 1.167-8.330) as significant independent predictors. The identification of risk factors amongst our local population helped to refine the criteria used for target active surveillance screening for CRE amongst inpatients at time of hospital admission.Keywords
This publication has 23 references indexed in Scilit:
- Environmental Contamination by Carbapenem-Resistant EnterobacteriaceaeJournal of Clinical Microbiology, 2013
- The Excess Financial Burden of Multidrug Resistance in Severe Gram-negative Infections in Singaporean HospitalsAnnals of the Academy of Medicine, Singapore, 2012
- Molecular Characterization of Newly EmergedblaKPC-2-Producing Klebsiella pneumoniae in SingaporeJournal of Clinical Microbiology, 2012
- Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patientScandinavian Journal of Infectious Diseases, 2011
- Development of High-Level Carbapenem Resistance inKlebsiella pneumoniaeAmong Patients with Prolonged Hospitalization and Carbapenem ExposureMicrobial Drug Resistance, 2010
- Successful Eradication of a Monoclonal Strain ofKlebsiella pneumoniaeduring aK. pneumoniaeCarbapenemase-ProducingK. pneumoniaeOutbreak in a Surgical Intensive Care Unit in Miami, FloridaInfection Control & Hospital Epidemiology, 2010
- Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae InfectionInfection Control & Hospital Epidemiology, 2010
- KPC-Producing Extreme Drug-Resistant Klebsiella pneumoniae Isolate from a Patient with Diabetes Mellitus and Chronic Renal Failure on Hemodialysis in South KoreaAntimicrobial Agents and Chemotherapy, 2010
- Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from IndiaAntimicrobial Agents and Chemotherapy, 2009
- Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from ChinaAntimicrobial Agents and Chemotherapy, 2007